Vita Coco Company, Inc.·4

Apr 28, 5:16 PM ET

Roper Martin 4

4 · Vita Coco Company, Inc. · Filed Apr 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Vita Coco (COCO) CEO Martin Roper Exercises Options, Sells Shares

What Happened

  • Martin Roper, CEO of Vita Coco Company, exercised a total of 50,000 stock options (25,000 on 2026-04-24 and 25,000 on 2026-04-27) at a strike price of $10.18, paying $508,900 in exercise costs. He sold the 50,000 resulting shares in two open-market transactions (25,000 shares each day) at $50.00 per share, generating $2,500,000 in gross proceeds. The Form 4 also reports the related derivative conversions at $0.00, reflecting the option-to-share conversion.

Key Details

  • Transaction dates and prices:
    • 2026-04-24: exercised 25,000 options @ $10.18 (cost $254,450); sold 25,000 shares @ $50.00 (proceeds $1,250,000).
    • 2026-04-27: exercised 25,000 options @ $10.18 (cost $254,450); sold 25,000 shares @ $50.00 (proceeds $1,250,000).
  • Net proceeds (approx.): $2,500,000 gross sales − $508,900 exercise cost = ~$1,991,100 before taxes/fees.
  • Sales were effected pursuant to a Rule 10b5‑1 trading plan (footnote F1).
  • The filing was submitted 2026-04-28 for transactions on 2026-04-24 and 2026-04-27 — within the SEC’s two-business-day Form 4 reporting window.
  • Shares owned after the transactions are not specified in the information provided in this Form 4.

Context

  • This was essentially a same-day exercise-and-sell (cashless-style) sequence: options were exercised and the resulting shares were sold shortly thereafter. Such transactions are often executed under pre-established 10b5‑1 plans and can be routine liquidity events rather than a clear signal about the CEO’s view of the company. The Form’s derivative entries at $0.00 reflect conversion/cancellation of the exercised options.

Insider Transaction Report

Form 4
Period: 2026-04-24
Roper Martin
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-24$10.18/sh+25,000$254,450323,484 total
  • Sale

    Common Stock

    [F1]
    2026-04-24$50.00/sh25,000$1,250,000298,484 total
  • Exercise/Conversion

    Common Stock

    2026-04-27$10.18/sh+25,000$254,450323,484 total
  • Sale

    Common Stock

    [F1]
    2026-04-27$50.00/sh25,000$1,250,000298,484 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F5]
    2026-04-2425,000400,214 total
    Exercise: $10.18Exp: 2029-09-19Common Stock (25,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F5]
    2026-04-2725,000375,214 total
    Exercise: $10.18Exp: 2029-09-19Common Stock (25,000 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: by Chris Roper FT)
    215,631
  • Common Stock

    [F3]
    (indirect: by Peter Roper FT)
    216,131
  • Common Stock

    [F4]
    (indirect: by Thomas Roper FT)
    216,131
  • Common Stock

    (indirect: By Spouse)
    41,200
  • Non-Qualified Stock Option (Right to Buy)

    [F5]
    Exercise: $10.18Exp: 2031-01-11Common Stock (40,950 underlying)
    40,950
  • Non-Qualified Stock Option (Right to Buy)

    [F6]
    Exercise: $15.00Exp: 2031-10-21Common Stock (298,507 underlying)
    298,507
  • Non-Qualified Stock Option (Right to Buy)

    [F7]
    Exercise: $16.91Exp: 2033-03-10Common Stock (46,875 underlying)
    46,875
  • Non-Qualified Stock Option (Right to Buy)

    [F5]
    Exercise: $16.91Exp: 2033-03-10Common Stock (185,133 underlying)
    185,133
  • Non-Qualified Stock Option (Right to Buy)

    [F8]
    Exercise: $26.18Exp: 2034-03-04Common Stock (62,743 underlying)
    62,743
  • Non-Qualified Stock Option (Right to Buy)

    [F9]
    Exercise: $32.78Exp: 2035-03-03Common Stock (70,715 underlying)
    70,715
Footnotes (9)
  • [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]These shares are held by the Christopher G. Roper Exempt Family Trust.
  • [F3]These shares are held by the Peter S. Roper Exempt Family Trust.
  • [F4]These shares are held by the Thomas L. Roper Exempt Family Trust.
  • [F5]The stock option is fully vested and currently exercisable.
  • [F6]The stock option vests in four equal annual installments beginning on November 27, 2022.
  • [F7]The stock option vests in four equal annual installments beginning on March 10, 2024.
  • [F8]The stock option vests in four equal annual installments beginning on March 4, 2025.
  • [F9]The stock option vests in four equal annual installments beginning on March 3, 2026.
Signature
/s/ Alison Klein, attorney-in-fact for Martin Roper|2026-04-28

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT